Article
Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study.
European journal of clinical pharmacology - 1 Jan 2004
Kawanishi Chiaki, Lundgren Stefan, Agren Hans, Bertilsson Leif
Abstract excerpt
OBJECTIVE: Recent studies have revealed that genetic polymorphisms of cytochrome P(450) 2D6 (CYP2D6) are among the factors that determine the interindividual differences in the metabolism and response to antidepressants. We investigated the relationship between persistent mood disorders and the duplication of the CYP2D6 gene, which encodes an enzyme with increased activity. METHODS: We screened the prevalence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
